Latest News for: novo

Edit

It’s been three months since Lilly launched its obesity pill. Most people are taking Novo’s ...

Wall Street Journal 15 Jul 2026
The market leader in obesity shots, Lilly hasn’t made a major dent in the pill market yet ... .
Edit

Novo estudo da Oxford Economics mostra o impacto social e econômico dos bares

Enid News & Eagle 14 Jul 2026
LONDRES--(BUSINESS WIRE)--jul 14, 2026-- ... .
Edit

Autonomous Healthcare Receives FDA De Novo Marketing Authorization for Syncron-E™, the First Device in a New FDA Category of Ventilator Waveform Analysis Software

PR Newswire 14 Jul 2026
Food and Drug Administration (FDA) has granted the De Novo marketing authorization for Syncron-E™, its software that supports respiratory therapists' assessment of patient-ventilator asynchrony by detecting evidence of ineffective efforts.
Edit

Novo Nordisk A/S - share repurchase programme (Novo Nordisk A/S)

Public Technologies 13 Jul 2026
2026-07-13 14.24.39 CEST Novo Nordisk A/S - Changes in company's own shares Novo Nordisk A/S - share repurchase programme ... Novo Nordisk is a leading global healthcare company founded in 1923 and headquartered in Denmark.
Edit

Novo Nordisk A/S – Share repurchase programme (Form 6-K) (Novo Nordisk A/S)

Public Technologies 13 Jul 2026
Novo Nordisk A/S - Share repurchase programme ... Under the programme initiated 6 May 2026, Novo Nordisk will repurchase B shares for an amount up to DKK 11,200,000,010.45 in the period from 6 May 2026 to 1 February 2027 ... Novo Nordisk A/S ... Novo Allé 1.
Edit

FDA Grants De Novo Classification to Claria Medical for Device Designed to Improve Safety and ...

Nasdaq Globe Newswire 13 Jul 2026
FDA grants De Novo classification to Claria Medical for device designed to improve the safety and efficiency of hysterectomy procedures ... .
Edit

Novo Nordisk A/S - share repurchase programme

Nasdaq Globe Newswire 13 Jul 2026
Bagsværd, Denmark, 13 July 2026 – On 6 May 2026, Novo Nordisk initiated a share repurchase ...
Edit

Novo Nordisk's denecimig (Mim8) demonstrated positive results in long term safety and efficacy in phase ...

My Horry News 12 Jul 2026
Presented interim FRONTIER4 data evaluate the long-term safety and ...
Edit

Novo Nordisk’s denecimig (Mim8) demonstrated positive results in long term safety and efficacy in phase 3 hemophilia A FRONTIER extension study at ISTH 2026 (Novo Nordisk A/S)

Public Technologies 11 Jul 2026
Novo Nordisk A/S published this content on July 11, 2026, and is solely ...
Edit

Novo Nordisk's denecimig (Mim8) demonstrated positive results in long term safety and efficacy in phase 3 hemophilia A FRONTIER extension study at ISTH 2026

PR Newswire 11 Jul 2026
These results and other data across Novo Nordisk's hemophilia portfolio were presented at the International Society on Thrombosis and Haemostasis (ISTH) Congress in Paris ... Development at Novo Nordisk.
Edit

32nd Annual General Meeting resolutions of Krka, d. d., Novo mesto (KRKA dd)

Public Technologies 10 Jul 2026
) INI-344/26. KRKA, d. d., Novo mesto. 32nd Annual General Meeting resolutions of Krka, d. d., Novo mesto ... The adopted resolutions are attached ... Krka, d. d., Novo mesto.
Edit

No easy answers: European research consortia take on major challenges

Caledonian Record 10 Jul 2026
COPENHAGEN, Denmark, July 10, 2026 (GLOBE NEWSWIRE) -- Nine ...
Edit

India gets Novo Nordisk's once-weekly insulin injection Awiqli for adults with diabetes

Hindustan Times 09 Jul 2026
. India News ....
Edit

Novo Nordisk India rolls-out a once-weekly basal insulin Awiqli

Business Line 09 Jul 2026
The product will be imported from Denmark and is priced at ₹2611 for a 1 ml pen (700 insulin units) ....
Edit

Novo Nordisk launches once-weekly insulin shot in India at Rs 261 a week, aims to help more diabetics switch

Indian Express 09 Jul 2026
.

Article Search

tools
×
×
×
×